| Name | Hydrocortisone 21-hemisuccinate |
|---|---|
| Synonyms |
HYDROCORTISONEHEMISUCCINATE(ANHYDROUS)
Cortisol 21-(4-oxo-4-hydroxybutanoate) MFCD00046256 saxizon 21-(3-Cboxy-1-oxopropoxy)-11β,17-dihydroxypregn-4-ene-3,20-dione 20-dione 21-hemisuccinate Butanedioic acid, mono(11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl) ester hydrocortisone hemisuccinate ester C12888 2-oxoethoxy) Hydrocortisone hydrogen succinate 11b,17a,21-Trihydroxy-4-pregnene-3,20-dione 21-hemisuccinate 4-PREGNEN-11-BETA, 17,21-TRIOL-3,20-DIONE 21-HEMISUCCINATE Butanedioic acid, mono[(11α)-11,17-dihydroxy-3,20-dioxopregn-4-en-21-yl] ester hydrocortisone21-hemisuccinate*freeacid Pregn-4-ene-3,20-dione,21-(3-cboxy-1-oxopropoxy)-11,17-dihydroxy-, (11b) 4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid Hydrocortisone 21-he Hydrocortisone acetate half Kohaku Hydrocortisone 21-hemisuccinate //BP HYDROCORTISONE 21-HEMISUCCINATE Hydrocortisone hydrogen succinate CRS 4-PREGNEN-11β, 17, 21-TRIOL-3, 20-DIONE 21-HEMISUCCINATE 4-{[(11α)-11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl]oxy}-4-oxobutanoic acid Cortisol, 21-(hydrogen succinate) (8CI) 4-[(11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl)oxy]-4-oxobutanoic acid hydrocortisone21-succinate EINECS 218-612-3 21-Trihydroxy-4-pregnene-3 HYDROCORTISONE HEMISUCCINATE 4-(2-((8S,9S,10R,11S,13S,14S,17R) Hydrocortisone Succinate RS Hydrocortisone hemisuccinate anhydrous,Hydrocortisone 21-hemisuccinate Hydrocortizone Succinate HYDROCORTISONE HYDROGEN SUCCINATE HYDROCORTISONE SUCCINATE 17-dihydroxy-20-dion(11-beta)-preg-4-ene-21-(3-cboxy-1-oxopropoxy)-11 Cortisol, hydrogen succinate (7CI) cortisol,hydrogensuccinate cortisolsuccinate 21-(3-Cboxy-1-oxopropoxy)-11β,17α-dihydroxypregn-4-ene-3,20-dione 11β,17α,21-trihydroxy-4-pregnene-3,20-dione 21-hemisuccinate HYDROXYCORTISONE SUCCINATE Pregn-4-ene-3,20-dione, 21-(3-cboxy-1-oxopropoxy)-11,17-dihydroxy-, (11β) 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione21-(hydrogensuccinate) CORTISOL 21-HEMISUCCINATE hydrocortisone-21-O-hemisuccinate 4-(2-((8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic acid RMA-279 cortisol,21-(hydrogensuccinate) 4-PREGNEN-11BETA,17ALPHA,21-TRIOL-3,20-DIONE 21-HEMISUCCINATE Hydrocortisone Hemisuccinate Monomer hydrocortisone 21-(hydrogen succinate) (11-beta)-21-(3-cboxy-1-oxopropoxy)-11,17-dihydroxypreg-4-ene-3,20-dione 11,17-Dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl) CORTISOL HEMISUCCINATE Hydrocortisone hemisuccinate, 10 mM in DMSO 11BETA,17ALPHA,21-TRIHYDROXY-4-PREGNENE-3,20-DIONE 21-HEMISUCCINATE hydrocortisone 21-hemisuccinate*free acid |
| Description | Hydrocortisone hemisuccinate (Hydrocortisone 21-hemisuccinate), a physiological glucocorticoid, and is an orally active steroidal anti-inflammatory drug (SAID). Hydrocortisone hemisuccinate inhibits proinflammatory cytokine activity, with IC50s of 6.7 and 21.4 μM for IL-6 and IL-3, respectively. Hydrocortisone hemisuccinate can be used for the research of ulcerative colitis (UC)[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
IL-6:6.7 μM (IC50) IL-3:21.4 μM (IC50) |
| In Vitro | Hydrocortisone hemisuccinate inhibits IL-6 and IL-3 bioactivity, with IC50s of 6.7 and 21.4 μM, respectively, and shows no cytotoxic effects on IL-6-independent MH60 cells[3]. Hydrocortisone hemisuccinate (0.12-60 μM; 72 h) inhibits phytohemagglutinin (PHA) response in peripheral lymphocytes (PBL) and T-lymphocytes cultures[3]. |
| In Vivo | Hydrocortisone hemisuccinate (30 mg/kg; p.o. twice daily for 5 d) reduces the weight loss and increases the food intake in mice[2]. Animal Model: Male Sprague-Dawley rats (200-220 g, 10-11 weeks) are induced colitis[2] Dosage: 30 mg/kg Administration: P.o. twice daily for 5 days Result: Significantly decreased the disease activity index (DAI) scores and myeloperoxidase (MPO) activity compared to the 2, 4, 6-trinitrobenzenesulfonic acid (TNBS) group. Increased the body weight. |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 685.5±55.0 °C at 760 mmHg |
| Molecular Formula | C25H34O8 |
| Molecular Weight | 462.533 |
| Flash Point | 231.1±25.0 °C |
| Exact Mass | 462.225372 |
| PSA | 138.20000 |
| LogP | 2.13 |
| Vapour Pressure | 0.0±4.8 mmHg at 25°C |
| Index of Refraction | 1.587 |
| Storage condition | −20°C |
| Water Solubility | Practically insoluble in water, freely soluble in acetone and in anhydrous ethanol. It dissolves in dilute solutions of alkali carbonates and alkali hydroxides. |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xi |
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | TU5010147 |
|
~98%
2203-97-6 |
| Literature: Wang, Chao; Zhao, Ming; Qiu, Xuecai; Peng, Shiqi Bioorganic and Medicinal Chemistry, 2004 , vol. 12, # 16 p. 4403 - 4421 |